Olfactive Biosolutions Files Patent to Repurpose Food Molecules to Safely, Inexpensively Regulate Blood Pressure
Establishes Company as Creator of New ‘Food Molecules as Pharmaceuticals’ Category of Healthcare
Mountain View, CA. April 2, 2024 -- Olfactive Biosolutions, the creator of the new, food molecule-based approach to healthcare, recently filed a U.S. patent for proprietary food ingredient formulations to control blood pressure without prescription pharmaceuticals and with few, if any, side effects. Protenx™ for blood pressure joins the expanding line of Protenx products, which already features innovative products to control weight and regulate blood sugar.
Protenx for blood pressure uses food molecules to activate receptors in the human gut that reduce blood pressure and integrates into common consumer products such as coffee, tea or food, so does not require any changes in consumer routines.
With its proprietary blend of food ingredients, the Protenx line of products will continue to target olfactory and taste receptors in the gut (ectopic receptors) and elsewhere throughout the body to gain effects similar to pharmaceuticals. Coming Protenx products will:
-- Increase bronchodilation
-- Reduce inflammation
-- Promote muscle regeneration
-- Increase bone remodeling
-- Induce the release of neurotransmitters such as serotonin, GABA and dopamine
The Protenx line is slated for general availability in Q4 of 2024, and its proprietary formulations may be added to new or existing consumer products, either in beverages or food. The Protenx patent also allows for administration including but not limited to topically, sublingual lozenges, inhaled or administered in multiple other ways.
“We are replacing prescription pharmaceuticals with common food molecules, creating a new, inexpensive, easy-to-digest category of health care solutions,” said Nils Lommerin, President and CEO of Olfactive Biosolutions. “We believe regulating blood pressure is an important aspect of people’s health, and we are excited to have filed a new patent for Protenx to safely and inexpensively replace pharmaceuticals that currently control blood pressure in millions of people worldwide.
“Adding the patent for controlling blood pressure to the Protenx products for weight loss, with new products for other conditions to come, establishes us as the leader in the food as pharmaceuticals category of health care. There is nothing else like it on the market,” he said.
About Olfactive Biosolutions
Olfactive Biosolutions is the creator of the new “Food as Pharmaceuticals” category of healthcare. The company has developed world-leading receptor technology and expertise in both ectopic receptors in the gut, lungs, skin, heart, blood and elsewhere, and olfactory and taste receptors in the nose and tongue. Its unique technology demonstrates how ectopic receptors often perform the same physiological tasks as active pharmaceutical ingredients or APIs, and what ligands activate or inhibit them.
The same technology accurately measuers the actual taste and smell of existing products, allowing the company to anchor the hedonics of a customer’s product, so it tastes and smells exactly like the original even after the addition of Protenx.
The Olfactive Biosolutions team has deep expertise in receptor protein science, artificial intelligence (AI) and the food & beverage industry. The company has several well-known biotechnology and AI advisors from academia and the corporate world.
To learn more, visit https://olfactive.bio
Contacts
Investor Contact:
Nils Lommerin
(949) 205-5776
Media Contact:
Deb Stapleton
(650) 815-1239